Oviva

Business overview

Oviva is a digital healthcare provider focused on weight management and chronic conditions such as hypertension and type 2 diabetes. It delivers clinically validated programs combining nutrition, behavioral therapy, and, where appropriate, pharmacological treatment. Services are prescribed by physicians and delivered remotely through Oviva’s proprietary platform.

Oviva’s services are offered free-of-charge to eligible patients in Germany, the UK, and Switzerland. The public healthcare systems fully fund the treatment, compensating Oviva for delivering measurable health results.

Kinnevik's view

Oviva addresses a large and growing healthcare need in Europe, where more than 200 million adults live with obesity and related chronic conditions. The company has supported more than one million patients to date, tripled new patient intake over the past two years, and reached cash-flow profitability in 2025.

We believe Oviva is well positioned to become a European leader in AI-enabled virtual care. While recent technological advancements are accelerating innovation across the obesity care landscape, Oviva already operates at scale with advanced AI-driven initiatives embedded in its model. Combined with strong clinical outcomes, established reimbursement relationships, and a robust regulatory position, this creates a differentiated and defensible platform for long-term growth.